The Asia Pacific Virtual Clinical Trials Market would witness market growth of 7.9% CAGR during the forecast period (2020-2026). The growing rate of neurological diseases like tumors, depression, epilepsy, Parkinson’s, and Alzheimer’s combined with the increasing geriatric population are components anticipated to boost the growth of the virtual clinical trial market over the forecast period. Growing clinical trials to find reliable and effective solutions to cure or decline and prevent the spread of neurological disorders and age-related diseases are components that will boost the growth of the virtual clinical trials market during the forecast period.
Furthermore, the instance of tropical and infectious diseases that need new medicines and drugs in numerous countries is a component anticipated to boost the growth of the virtual clinical trial market during the forecast period. Moreover, the modernization of clinical trials to improve productivity and collect information from many sources is a component anticipated to propel the growth of the clinical trial market in the next few years.
Furthermore, the instance of tropical and infectious diseases that need new medicines and drugs in numerous countries is a component anticipated to boost the growth of the virtual clinical trial market during the forecast period. Moreover, the modernization of clinical trials to improve productivity and collect information from many sources is a component anticipated to propel the growth of the clinical trial market in the next few years.
Also, researchers studying cancer confronting major challenges in patient recruitment. Till June 2019, around 14,000 oncology trials were recruited actively with a participation rate of 3% to 8% of possible participants, with a slight number in minority and geriatric populations. Less rate of enrollment presents risks to the effectiveness of particular clinical studies. It may hinder the advancement in treatment and related advantages to results. Therefore, the low rate of recruitment and the requirement for a different population for oncology clinical researches are expected to fuel the acceptance of virtual clinical trials.
Based on Study Type, the market is segmented into Interventional, Observational, and Expanded Access and Others. Based on Indication, the market is segmented into Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and Other Indications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Virtual Clinical Trials Market in Asia Pacific is expected to register a CAGR of 7.9% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., ICON PLC, Laboratory Corporation of America Holdings (Covance, Inc.), Dassault Systemes SE (Medidata Solutions, Inc.), Oracle Corporation, Parexel International Corporation (Pamplona Capital Management), PRA Health Sciences, Inc. (KKR & Co., Inc.), Medpace Holdings, Inc., Medable, Inc. and Clinical Ink, Inc. (G.I. Partners)
Scope of the Study
Market Segments Covered in the Report:
By Study Type
- Interventional
- Observational
- Expanded Access
- Others
By Indication
- Oncology
- Cardiovascular
- Immunology
- Gastrointestinal
- Respiratory
- Endocrinology
- Ophthalmology
- Other Indications
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- IQVIA Holdings, Inc.
- ICON PLC
- Laboratory Corporation of America Holdings (Covance, Inc.)
- Dassault Systemes SE (Medidata Solutions, Inc.)
- Oracle Corporation
- Parexel International Corporation (Pamplona Capital Management)
- PRA Health Sciences, Inc. (KKR & Co., Inc.)
- Medpace Holdings, Inc.
- Medable, Inc.
- Clinical Ink, Inc. (G.I. Partners)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Virtual Clinical Trials Market, by Study Type
1.4.2 Asia Pacific Virtual Clinical Trials Market, by Indication
1.4.3 Asia Pacific Virtual Clinical Trials Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Nov) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
Chapter 4. Asia Pacific Virtual Clinical Trials Market by Study Type
4.1 Asia Pacific Interventional Market by Country
4.2 Asia Pacific Observational Market by Country
4.3 Asia Pacific Expanded Access Market by Country
Chapter 5. Asia Pacific Virtual Clinical Trials Market by Indication
5.1 Asia Pacific Oncology Market by Country
5.2 Asia Pacific Cardiovascular Market by Country
5.3 Asia Pacific Immunology Market by Country
5.4 Asia Pacific Gastrointestinal Market by Country
5.5 Asia Pacific Respiratory Market by Country
5.6 Asia Pacific Endocrinology Market by Country
5.7 Asia Pacific Ophthalmology Market by Country
5.8 Asia Pacific Other Indications Market by Country
Chapter 6. Asia Pacific Virtual Clinical Trials Market by Country
6.1 China Virtual Clinical Trials Market
6.1.1 China Virtual Clinical Trials Market by Study Type
6.1.2 China Virtual Clinical Trials Market by Indication
6.2 Japan Virtual Clinical Trials Market
6.2.1 Japan Virtual Clinical Trials Market by Study Type
6.2.2 Japan Virtual Clinical Trials Market by Indication
6.3 India Virtual Clinical Trials Market
6.3.1 India Virtual Clinical Trials Market by Study Type
6.3.2 India Virtual Clinical Trials Market by Indication
6.4 South Korea Virtual Clinical Trials Market
6.4.1 South Korea Virtual Clinical Trials Market by Study Type
6.4.2 South Korea Virtual Clinical Trials Market by Indication
6.5 Singapore Virtual Clinical Trials Market
6.5.1 Singapore Virtual Clinical Trials Market by Study Type
6.5.2 Singapore Virtual Clinical Trials Market by Indication
6.6 Malaysia Virtual Clinical Trials Market
6.6.1 Malaysia Virtual Clinical Trials Market by Study Type
6.6.2 Malaysia Virtual Clinical Trials Market by Indication
6.7 Rest of Asia Pacific Virtual Clinical Trials Market
6.7.1 Rest of Asia Pacific Virtual Clinical Trials Market by Study Type
6.7.2 Rest of Asia Pacific Virtual Clinical Trials Market by Indication
Chapter 7. Company Profiles
7.1 IQVIA Holdings, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Product Launches and Product Expansions:
7.2 ICON PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.1 Recent strategies and developments:
7.2.1.1 Partnerships, Collaborations, and Agreements:
7.2.1.2 Product Launches and Product Expansions:
7.2.1.3 Acquisition and Mergers:
7.3 Laboratory Corporation of America Holdings (Covance, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Product Launches and Product Expansions:
7.3.4.2 Acquisition and Mergers:
7.4 Dassault Systemes SE (Medidata Solutions, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Oracle Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.6 Parexel International Corporation (Pamplona Capital Management)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Product Launches and Product Expansions:
7.6.2.3 Geographical Expansions:
7.7 PRA Health Sciences, Inc. (KKR & Co., Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Recent strategies and developments:
7.7.4.1 Partnerships, Collaborations, and Agreements:
7.7.4.2 Product Launches and Product Expansions:
7.8 Medpace Holdings, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Recent strategies and developments:
7.8.3.1 Partnerships, Collaborations, and Agreements:
7.9 Medable, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Product Launches and Product Expansions:
7.10. Clinical Ink, Inc. (G.I. Partners)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Asia Pacific Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 2 Asia Pacific Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Virtual Clinical Trials Market
TABLE 4 Product Launches And Product Expansions– Virtual Clinical Trials Market
TABLE 5 Geographical Expansions – Virtual Clinical Trials Market
TABLE 6 Acquisition and Mergers– Virtual Clinical Trials Market
TABLE 7 Asia Pacific Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 8 Asia Pacific Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 9 Asia Pacific Interventional Market by Country, 2016 - 2019, USD Million
TABLE 10 Asia Pacific Interventional Market by Country, 2020 - 2026, USD Million
TABLE 11 Asia Pacific Observational Market by Country, 2016 - 2019, USD Million
TABLE 12 Asia Pacific Observational Market by Country, 2020 - 2026, USD Million
TABLE 13 Asia Pacific Expanded Access Market by Country, 2016 - 2019, USD Million
TABLE 14 Asia Pacific Expanded Access Market by Country, 2020 - 2026, USD Million
TABLE 15 Asia Pacific Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 16 Asia Pacific Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 17 Asia Pacific Oncology Market by Country, 2016 - 2019, USD Million
TABLE 18 Asia Pacific Oncology Market by Country, 2020 - 2026, USD Million
TABLE 19 Asia Pacific Cardiovascular Market by Country, 2016 - 2019, USD Million
TABLE 20 Asia Pacific Cardiovascular Market by Country, 2020 - 2026, USD Million
TABLE 21 Asia Pacific Immunology Market by Country, 2016 - 2019, USD Million
TABLE 22 Asia Pacific Immunology Market by Country, 2020 - 2026, USD Million
TABLE 23 Asia Pacific Gastrointestinal Market by Country, 2016 - 2019, USD Million
TABLE 24 Asia Pacific Gastrointestinal Market by Country, 2020 - 2026, USD Million
TABLE 25 Asia Pacific Respiratory Market by Country, 2016 - 2019, USD Million
TABLE 26 Asia Pacific Respiratory Market by Country, 2020 - 2026, USD Million
TABLE 27 Asia Pacific Endocrinology Market by Country, 2016 - 2019, USD Million
TABLE 28 Asia Pacific Endocrinology Market by Country, 2020 - 2026, USD Million
TABLE 29 Asia Pacific Ophthalmology Market by Country, 2016 - 2019, USD Million
TABLE 30 Asia Pacific Ophthalmology Market by Country, 2020 - 2026, USD Million
TABLE 31 Asia Pacific Other Indications Market by Country, 2016 - 2019, USD Million
TABLE 32 Asia Pacific Other Indications Market by Country, 2020 - 2026, USD Million
TABLE 33 Asia Pacific Virtual Clinical Trials Market by Country, 2016 - 2019, USD Million
TABLE 34 Asia Pacific Virtual Clinical Trials Market by Country, 2020 - 2026, USD Million
TABLE 35 China Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 36 China Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 37 China Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 38 China Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 39 China Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 40 China Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 41 Japan Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 42 Japan Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 43 Japan Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 44 Japan Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 45 Japan Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 46 Japan Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 47 India Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 48 India Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 49 India Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 50 India Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 51 India Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 52 India Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 53 South Korea Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 54 South Korea Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 55 South Korea Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 56 South Korea Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 57 South Korea Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 58 South Korea Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 59 Singapore Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 60 Singapore Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 61 Singapore Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 62 Singapore Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 63 Singapore Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 64 Singapore Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 65 Malaysia Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 66 Malaysia Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 67 Malaysia Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 68 Malaysia Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 69 Malaysia Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 70 Malaysia Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 71 Rest of Asia Pacific Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 72 Rest of Asia Pacific Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 73 Rest of Asia Pacific Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 74 Rest of Asia Pacific Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 75 Rest of Asia Pacific Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 76 Rest of Asia Pacific Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 77 Key information – IQVIA Holdings, Inc.
TABLE 78 Key Information – ICON PLC
TABLE 79 Key Information – Laboratory Corporation of America holdings
TABLE 80 Key Information – Dassault Systemes SE
TABLE 81 Key Information – Oracle Corporation
TABLE 82 Key Information – PAREXEL International Corporation
TABLE 83 Key Information – PRA Health Sciences, Inc.
TABLE 84 key Information – Medpace Holdings, Inc.
TABLE 85 Key Information – Medable, Inc.
TABLE 86 Key Information – Clinical Ink, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Feb – 2020, Dec) Leading Players
FIG 5 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
FIG 6 Recent strategies and developments: IQVIA Holdings, Inc.
FIG 7 Recent strategies and developments: ICON PLC
FIG 8 Recent strategies and developments: Laboratory Corporation of America
FIG 9 Recent strategies and developments: Dassault Systemes SE
FIG 10 Recent strategies and developments: Oracle Corporation
FIG 11 Recent strategies and developments: Parexel International Corporation
FIG 12 Recent strategies and developments: PRA Health Sciences, Inc.
FIG 13 Recent strategies and developments: Medable, Inc.